Management

Facing a COVID-19 Resurgence and Unable to Act

Coronavirus cases are going up, but lockdowns seem less realistic than ever.

Oversight

How — and When — Can the Coronavirus Vaccine Become a Reality?

It is likely we’ll eventually have a coronavirus vaccine — but perhaps not as quickly as some expect. From development, to clinical trials and distribution, ProPublica reporter Caroline Chen explains the tremendous challenges that lie ahead.

Oversight

House Democrat Asks Inspectors General to Review Agencies' Reopening Plans

"Your continued oversight is critical to protect the health and safety of our government’s most valuable resource: its federal workforce," Connolly wrote. 

Oversight

For Experts Who Study Coronaviruses, a Grim Vindication

They warned that the next great pandemic would be a coronavirus, but research funding went to studying other threats.

Management

Analysis: Could Pressure for COVID-19 Drugs Lead the FDA to Lower Its Standards?

The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?

Management

The Critical Need for Reliable Antibody Testing for COVID-19

While there are some good tests out there, not all are equally reliable, the director of the National Institutes of Health explains.

Defense

Army Scientists: All Strains of COVID-19 Can Be Covered by One Vaccine

The service is on track to produce a vaccine against multiple coronavirus strains by the end of the year. But making it available is the CDC’s job.